IL-15 FUSION PROTEIN ENHANCED ADOPTIVE CELL THERAPEUTICS

摘要

Combination therapies which include natural killer (NK) cells, IL-15 super agonist and/or at least one chemotherapeutic agent enhance the anti-tumor activity of the NK cells. In certain embodiments, a method of preventing or treating cancer, comprises administering to a patient in need thereof, an effective amount of an adoptive cell therapy and a pharmaceutical composition comprising a therapeutically effective amount of at least one chemotherapeutic agent, thereby treating cancer.